Download Files:
Pilaralisib
Price range: 48 CAD through 949 CAD
Products Details
Product Description
– Pilaralisib (XL-147) is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
Web ID
– T2365
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C25H25ClN6O4S
References
– Foster P, et al. Mol Cancer Ther. 2015, 14(4), 931-940.
CAS Number
– 934526-89-3
Molecular Weight
– C25H25ClN6O4S
Compound Purity
– 0.9953
SMILES
– COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1
Pathway
– PI3K/Akt/mTOR signaling
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
